Skip to main content
. 2015 Oct 20;3:45. doi: 10.1186/s40425-015-0090-0

Fig. 1.

Fig. 1

Survival analysis of elderly breast cancer patients according to CD8+ T-cell responses to Her-2peptides in vitro. Survival analysis of elderly patients (n = 38) grouped according to CD8+ T-cell responses to Her-2 (CD8 response), CD4+ and CD8+ T-cell responses (CD4 & CD8response) and CD4+ T-cell responses to Her-2 (CD4 response)